← FDA Drug Approvals (Drugs@FDA)

ZAVESCA

NDA · New Drug Application · Sponsor: ACTELION · Approved 2003-07-31

Drug application

FDA Application #

NDA021348

Application type

New Drug Application

Brand name

ZAVESCA

Generic name

MIGLUSTAT

Active ingredients

MIGLUSTAT

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ACTELION

Manufacturer

Actelion Pharmaceuticals US, Inc.

First approval

2003-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown